Protein networks and activation of lymphocytes

Current Opinion in Immunology

Volumn 33, Issue , 2015, Pages 78-85

  Helou, Ynes A ^a   Salomon, Arthur R ^b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; PROTEIN KINASE ZAP 70; PROTEOME; T LYMPHOCYTE RECEPTOR; PHOSPHOTRANSFERASE; PROTEIN BINDING;

ACCURACY; AFFINITY PURIFICATION MASS SPECTROMETRY; ANALOG SENSITIVE KINASE TECHNOLOGY; ANALYTICAL PARAMETERS; ARTICLE; CYTOMETRY; ENZYME SUBSTRATE; FALSE DISCOVERY RATE; GENETIC ENGINEERING AND GENE TECHNOLOGY; IMMUNOPHENOTYPING; INTRACELLULAR SIGNALING; ISOTOPE LABELING; JURKAT CELL LINE; LIQUID CHROMATOGRAPHY; LYMPHOCYTE ACTIVATION; MASS SPECTROMETRY; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; PHOSPHOPROTEOMICS; PROTEIN ANALYSIS; PROTEIN NETWORK; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEOMICS; QUANTITATIVE ANALYSIS; SHOTGUN PROTEOMICS; SINGLE CELL ANALYSIS; STATISTICAL ANALYSIS; TANDEM MASS SPECTROMETRY; ANIMAL; BIOLOGY; ENZYME SPECIFICITY; HUMAN; IMMUNOLOGY; INFORMATION PROCESSING; LYMPHOCYTE; METABOLISM; PHOSPHORYLATION; PROCEDURES; SIGNAL TRANSDUCTION; STATISTICAL MODEL;

ANIMALS; COMPUTATIONAL BIOLOGY; DATASETS AS TOPIC; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MODELS, STATISTICAL; PHOSPHORYLATION; PHOSPHOTRANSFERASES; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION; SINGLE-CELL ANALYSIS; SUBSTRATE SPECIFICITY;

EID: 84922683472     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2015.01.019     Document Type: Review

References (82)

1. Romanova E.V., Dowd S.E., Sweedler J.V. Quantitation of endogenous peptides using mass spectrometry based methods. Curr Opin Chem Biol 2013, 17:801-808.
2. Schulze W.X., Usadel B. Quantitation in mass-spectrometry-based proteomics. Annu Rev Plant Biol 2010, 61:491-516.
3. Ji Q., Ding Y., Salomon A.R. SLP-76 N-terminal tyrosine residues regulate a dynamic signaling equilibrium involving feedback of proximal TCR signaling. Mol Cell Proteomics 2015, 14:30-40.
4. Lichtenfels R., Rappl G., Hombach A.A., Recktenwald C.V., Dressler S.P., Abken H., Seliger B. A proteomic view at T cell costimulation. PLOS ONE 2012, 7:e32994.
5. Ma D., Cao W., Kapur A., Felder M., Scarlett C.O., Patankar M.S., Li L. Differential expression of proteins in naive and IL-2 stimulated primary human NK cells identified by global proteomic analysis. J Proteomics 2013, 91:151-163.
6. Diandong H., Kefeng S., Weixin F., Zaifu L. Proteomic analysis of NK92-MI cells activated by neuropeptide substance P. Neuropeptides 2013, 47:157-162.
7. Chen Y.J., Yu C.C., Chen S.T., Chen T.Y., Liao H.F. Functional regulation and proteomic characterization of human natural killer cells through recombinant human granulocyte-colony stimulating factor treatment. Proteomics Clin Appl 2009, 3:563-573.
8. Huang X., Shen Y., Liu M., Bi C., Jiang C., Iqbal J., McKeithan T.W., Chan W.C., Ding S.J., Fu K. Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma. Am J Pathol 2012, 181:26-33.
9. Salonen J., Ronnholm G., Kalkkinen N., Vihinen M. Proteomic changes during B cell maturation: 2D-DIGE approach. PLOS ONE 2013, 8:e77894.
10. Scheiter M., Lau U., van Ham M., Bulitta B., Grobe L., Garritsen H., Klawonn F., Konig S., Jansch L. Proteome analysis of distinct developmental stages of human natural killer (NK) cells. Mol Cell Proteomics 2013, 12:1099-1114.
11. Kashuba E., Eagle G.L., Bailey J., Evans P., Welham K.J., Allsup D., Cawkwell L. Proteomic analysis of B-cell receptor signaling in chronic lymphocytic leukaemia reveals a possible role for kininogen. J Proteomics 2013, 91:478-485.
12. Stranneheim H., Orre L.M., Lehtio J., Flygare J. A comparison between protein profiles of B cell subpopulations and mantle cell lymphoma cells. Proteome Sci 2009, 7:43.
13. Deeb S.J., D'Souza R.C., Cox J., Schmidt-Supprian M., Mann M. Super-SILAC allows classification of diffuse large B-cell lymphoma subtypes by their protein expression profiles. Mol Cell Proteomics 2012, 11:77-89.
14. Boyd R.S., Jukes-Jones R., Walewska R., Brown D., Dyer M.J., Cain K. Protein profiling of plasma membranes defines aberrant signaling pathways in mantle cell lymphoma. Mol Cell Proteomics 2009, 8:1501-1515.
15. de Wet B., Zech T., Salek M., Acuto O., Harder T. Proteomic characterization of plasma membrane-proximal T cell activation responses. J Biol Chem 2011, 286:4072-4080.
16. Ghosh D., Lippert D., Krokhin O., Cortens J.P., Wilkins J.A. Defining the membrane proteome of NK cells. J Mass Spectrom 2010, 45:1-25.
17. Schmidt H., Gelhaus C., Nebendahl M., Lettau M., Lucius R., Leippe M., Kabelitz D., Janssen O. Effector granules in human T lymphocytes: the luminal proteome of secretory lysosomes from human T cells. Cell Commun Signal 2011, 9:4.
18. Schmidt H., Gelhaus C., Nebendahl M., Lettau M., Lucius R., Leippe M., Kabelitz D., Janssen O. Effector granules in human T lymphocytes: proteomic evidence for two distinct species of cytotoxic effector vesicles. J Proteome Res 2011, 10:1603-1620.
19. Schmidt H., Gelhaus C., Nebendahl M., Lettau M., Watzl C., Kabelitz D., Leippe M., Janssen O. 2-D DIGE analyses of enriched secretory lysosomes reveal heterogeneous profiles of functionally relevant proteins in leukemic and activated human NK cells. Proteomics 2008, 8:2911-2925.
20. Meissner F., Scheltema R.A., Mollenkopf H.J., Mann M. Direct proteomic quantification of the secretome of activated immune cells. Science 2013, 340:475-478.
21. Boutz D.R., Horton A.P., Wine Y., Lavinder J.J., Georgiou G., Marcotte E.M. Proteomic identification of monoclonal antibodies from serum. Anal Chem 2014, 86:4758-4766.
22. Admon A., Bassani-Sternberg M. The Human Immunopeptidome Project, a suggestion for yet another postgenome next big thing. Mol Cell Proteomics 2011, 10. O111 011833.
23. Mester G., Hoffmann V., Stevanovic S. Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands. Cell Mol Life Sci 2011, 68:1521-1532.
24. Caron E., Vincent K., Fortier M.H., Laverdure J.P., Bramoulle A., Hardy M.P., Voisin G., Roux P.P., Lemieux S., Thibault P., et al. The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol Syst Biol 2011, 7:533.
25. Espinosa G., Collado J.A., Scholz E., Mestre-Ferrer A., Kuse N., Takiguchi M., Carrascal M., Canals F., Pujol-Borrell R., Jaraquemada D., et al. Peptides presented by HLA class I molecules in the human thymus. J Proteomics 2013, 94:23-36.
26. Granados D.P., Sriranganadane D., Daouda T., Zieger A., Laumont C.M., Caron-Lizotte O., Boucher G., Hardy M.P., Gendron P., Cote C., et al. Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides. Nat Commun 2014, 5:3600.
27. Kumari S., Walchli S., Fallang L.E., Yang W., Lund-Johansen F., Schumacher T.N., Olweus J. Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes. Proc Natl Acad Sci U S A 2014, 111:403-408.
28. Malissen B., Gregoire C., Malissen M., Roncagalli R. Integrative biology of T cell activation. Nat Immunol 2014, 15:790-797.
29. Kaake R.M., Wang X., Burke A., Yu C., Kandur W., Yang Y., Novtisky E.J., Second T., Duan J., Kao A., et al. A new in vivo cross-linking mass spectrometry platform to define protein-protein interactions in living cells. Mol Cell Proteomics 2014, 13:3533-3543.
30. Budayeva H.G., Cristea I.M. A mass spectrometry view of stable and transient protein interactions. Adv Exp Med Biol 2014, 806:263-282.
31. Walzthoeni T., Leitner A., Stengel F., Aebersold R. Mass spectrometry supported determination of protein complex structure. Curr Opin Struct Biol 2013, 23:252-260.
32. Marcilla M., Albar J.P. Quantitative proteomics: a strategic ally to map protein interaction networks. IUBMB Life 2013, 65:9-16.
33. Armean I.M., Lilley K.S., Trotter M.W. Popular computational methods to assess multiprotein complexes derived from label-free affinity purification and mass spectrometry (AP-MS) experiments. Mol Cell Proteomics 2013, 12:1-13.
34. Choi H. Computational detection of protein complexes in AP-MS experiments. Proteomics 2012, 12:1663-1668.
35. Gingras A.C., Raught B. Beyond hairballs: the use of quantitative mass spectrometry data to understand protein-protein interactions. FEBS Lett 2012, 586:2723-2731.
36. Dunham W.H., Mullin M., Gingras A.C. Affinity-purification coupled to mass spectrometry: basic principles and strategies. Proteomics 2012, 12:1576-1590.
37. Orr S.J., Boutz D.R., Wang R., Chronis C., Lea N.C., Thayaparan T., Hamilton E., Milewicz H., Blanc E., Mufti G.J., et al. Proteomic and protein interaction network analysis of human T lymphocytes during cell-cycle entry. Mol Syst Biol 2012, 8:573.
38. Fierro-Monti I., Echeverria P., Racle J., Hernandez C., Picard D., Quadroni M. Dynamic impacts of the inhibition of the molecular chaperone Hsp90 on the T-cell proteome have implications for anti-cancer therapy. PLOS ONE 2013, 8:e80425.
39. Roncagalli R., Hauri S., Fiore F., Liang Y., Chen Z., Sansoni A., Kanduri K., Joly R., Malzac A., Lahdesmaki H., et al. Quantitative proteomics analysis of signalosome dynamics in primary T cells identifies the surface receptor CD6 as a Lat adaptor-independent TCR signaling hub. Nat Immunol 2014, 15:384-392.
40. Li X.W., Rees J.S., Xue P., Zhang H., Hamaia S.W., Sanderson B., Funk P.E., Farndale R.W., Lilley K.S., Perrett S., et al. New insights into the DT40 B cell receptor cluster using a proteomic proximity labeling assay. J Biol Chem 2014, 289:14434-14447.
41. Helou Y.A., Nguyen V., Beik S.P., Salomon A.R. ERK positive feedback regulates a widespread network of tyrosine phosphorylation sites across canonical T cell signaling and actin cytoskeletal proteins in Jurkat T cells. PLOS ONE 2013, 8:e69641.
42. Cao L., Ding Y., Hung N., Yu K., Ritz A., Raphael B.J., Salomon A.R. Quantitative phosphoproteomics reveals SLP-76 dependent regulation of PAG and Src family kinases in T cells. PLOS ONE 2012, 7:e46725.
43. Nguyen V., Cao L., Lin J.T., Hung N., Ritz A., Yu K., Jianu R., Ulin S.P., Raphael B.J., Laidlaw D.H., et al. A new approach for quantitative phosphoproteomic dissection of signaling pathways applied to T cell receptor activation. Mol Cell Proteomics 2009, 8:2418-2431.
44. Salek M., McGowan S., Trudgian D.C., Dushek O., de Wet B., Efstathiou G., Acuto O. Quantitative phosphoproteome analysis unveils LAT as a modulator of CD3zeta and ZAP-70 tyrosine phosphorylation. PLOS ONE 2013, 8:e77423.
45. Brockmeyer C., Paster W., Pepper D., Tan C.P., Trudgian D.C., McGowan S., Fu G., Gascoigne N.R.J., Acuto O., Salek M. T cell receptor (TCR)-induced tyrosine phosphorylation dynamics identifies THEMIS as a new TCR signalosome component. J Biol Chem 2011, 286:7535-7547.
46. Chylek L.A., Akimov V., Dengjel J., Rigbolt K.T., Hu B., Hlavacek W.S., Blagoev B. Phosphorylation site dynamics of early T-cell receptor signaling. PLOS ONE 2014, 9:e104240.
47. Matsumoto M., Oyamada K., Takahashi H., Sato T., Hatakeyama S., Nakayama K.I. Large-scale proteomic analysis of tyrosine-phosphorylation induced by T-cell receptor or B-cell receptor activation reveals new signaling pathways. Proteomics 2009, 9:3549-3563.
48. Kim J.E., White F.M. Quantitative analysis of phosphotyrosine signaling networks triggered by CD3 and CD28 costimulation in Jurkat cells. J Immunol 2006, 176:2833-2843.
49. Rolland D., Basrur V., Conlon K., Wolfe T., Fermin D., Nesvizhskii A.I., Lim M.S., Elenitoba-Johnson K.S. Global phosphoproteomic profiling reveals distinct signatures in B-cell non-Hodgkin lymphomas. Am J Pathol 2014, 184:1331-1342.
50. McDonnell S.R., Hwang S.R., Rolland D., Murga-Zamalloa C., Basrur V., Conlon K.P., Fermin D., Wolfe T., Raskind A., Ruan C., et al. Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK-mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphoma. Blood 2013, 122:958-968.
51. Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal 2009, 2:ra46.
52. Jayasundera K.B., Iliuk A.B., Nguyen A., Higgins R., Geahlen R.L., Tao W.A. Global phosphoproteomics of activated B cells using complementary metal ion functionalized soluble nanopolymers. Anal Chem 2014, 86:6363-6371.
53. Pighi C., Gu T.L., Dalai I., Barbi S., Parolini C., Bertolaso A., Pedron S., Parisi A., Ren J., Cecconi D., et al. Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. Cell Oncol 2011, 34:141-153.
54. Gioia R., Leroy C., Drullion C., Lagarde V., Etienne G., Dulucq S., Lippert E., Roche S., Mahon F.X., Pasquet J.M. Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells. Blood 2011, 118:2211-2221.
55. Rubbi L., Titz B., Brown L., Galvan E., Komisopoulou E., Chen S.S., Low T., Tahmasian M., Skaggs B., Muschen M., et al. Global phosphoproteomics reveals crosstalk between Bcr-Abl and negative feedback mechanisms controlling Src signaling. Sci Signal 2011, 4:ra18.
56. Ruperez P., Gago-Martinez A., Burlingame A.L., Oses-Prieto J.A. Quantitative phosphoproteomic analysis reveals a role for serine and threonine kinases in the cytoskeletal reorganization in early T cell receptor activation in human primary T cells. Mol Cell Proteomics 2012, 11:171-186.
57. Navarro M.N., Goebel J., Feijoo-Carnero C., Morrice N., Cantrell D.A. Phosphoproteomic analysis reveals an intrinsic pathway for the regulation of histone deacetylase 7 that controls the function of cytotoxic T lymphocytes. Nat Immunol 2011, 12:352-361.
58. Tsai C.M., Wu H.Y., Su T.H., Kuo C.W., Huang H.W., Chung C.H., Chen C.S., Khoo K.H., Chen Y.J., Lin K.I. Phosphoproteomic analyses reveal that galectin-1 augments the dynamics of B-cell receptor signaling. J Proteomics 2014, 103:241-253.
59. Caruthers N.J., Stemmer P.M., Shin N., Dombkowski A., Caruso J.A., Gill R., Rosenspire A. Mercury alters B-cell protein phosphorylation profiles. J Proteome Res 2014, 13:496-505.
60. Hunter T., Sefton B.M. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci U S A 1980, 77:1311-1315.
61. Iwai L.K., Benoist C., Mathis D., White F.M. Quantitative phosphoproteomic analysis of T cell receptor signaling in diabetes prone and resistant mice. J Proteome Res 2010, 9:3135-3145.
62. Diz A.P., Carvajal-Rodriguez A., Skibinski D.O. Multiple hypothesis testing in proteomics: a strategy for experimental work. Mol Cell Proteomics 2011, 10. M110 004374.
63. Chadeau-Hyam M., Campanella G., Jombart T., Bottolo L., Portengen L., Vineis P., Liquet B., Vermeulen R.C. Deciphering the complex: methodological overview of statistical models to derive OMICS-based biomarkers. Environ Mol Mutagen 2013, 54:542-557.
64. Storey J.D. The positive false discovery rate: a Bayesian interpretation and the q-value. Ann Stat 2003, 31:2013-2035.
65. Lopez M.S., Choy J.W., Peters U., Sos M.L., Morgan D.O., Shokat K.M. Staurosporine-derived inhibitors broaden the scope of analog-sensitive kinase technology. J Am Chem Soc 2013, 135:18153-18159.
66. Tan Y.X., Manz B.N., Freedman T.S., Zhang C., Shokat K.M., Weiss A. Inhibition of the kinase Csk in thymocytes reveals a requirement for actin remodeling in the initiation of full TCR signaling. Nat Immunol 2014, 15:186-194.
67. Au-Yeung B.B., Zikherman J., Mueller J.L., Ashouri J.F., Matloubian M., Cheng D.A., Chen Y., Shokat K.M., Weiss A. A sharp T-cell antigen receptor signaling threshold for T-cell proliferation. Proc Natl Acad Sci U S A 2014, 111:E3679-E3688.
68. Morandell S., Grosstessner-Hain K., Roitinger E., Hudecz O., Lindhorst T., Teis D., Wrulich O.A., Mazanek M., Taus T., Ueberall F., et al. QIKS - quantitative identification of kinase substrates. Proteomics 2010, 10:2015-2025.
69. Kettenbach A.N., Schweppe D.K., Faherty B.K., Pechenick D., Pletnev A.A., Gerber S.A. Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci Signal 2011, 4:rs5.
70. Xue L., Wang W.H., Iliuk A., Hu L., Galan J.A., Yu S., Hans M., Geahlen R.L., Tao W.A. Sensitive kinase assay linked with phosphoproteomics for identifying direct kinase substrates. Proc Natl Acad Sci U S A 2012, 109:5615-5620.
71. Chou M.F., Prisic S., Lubner J.M., Church G.M., Husson R.N., Schwartz D. Using bacteria to determine protein kinase specificity and predict target substrates. PLOS ONE 2012, 7:e52747.
72. Kettenbach A.N., Wang T., Faherty B.K., Madden D.R., Knapp S., Bailey-Kellogg C., Gerber S.A. Rapid determination of multiple linear kinase substrate motifs by mass spectrometry. Chem Biol 2012, 19:608-618.
73. Knight J.D., Tian R., Lee R.E., Wang F., Beauvais A., Zou H., Megeney L.A., Gingras A.C., Pawson T., Figeys D., et al. A novel whole-cell lysate kinase assay identifies substrates of the p38 MAPK in differentiating myoblasts. Skelet Muscle 2012, 2:5.
74. Garre S., Senevirathne C., Pflum M.K. A comparative study of ATP analogs for phosphorylation-dependent kinase-substrate crosslinking. Bioorg Med Chem 2014, 22:1620-1625.
75. Xue L., Geahlen R.L., Tao W.A. Identification of direct tyrosine kinase substrates based on protein kinase assay-linked phosphoproteomics. Mol Cell Proteomics 2013, 12:2969-2980.
76. Xue L., Wang P., Cao P., Zhu J.K., Tao W.A. Identification of ERK1 direct substrates using stable isotope labeled kinase assay-linked phosphoproteomics. Mol Cell Proteomics 2014, 13:3199-3210.
77. Satija R., Shalek A.K. Heterogeneity in immune responses: from populations to single cells. Trends Immunol 2014, 35:219-229.
78. Bjornson Z.B., Nolan G.P., Fantl W.J. Single-cell mass cytometry for analysis of immune system functional states. Curr Opin Immunol 2013, 25:484-494.
79. Chattopadhyay P.K., Gierahn T.M., Roederer M., Love J.C. Single-cell technologies for monitoring immune systems. Nat Immunol 2014, 15:128-135.
80. Bendall S.C., Simonds E.F., Qiu P., Amir el A.D., Krutzik P.O., Finck R., Bruggner R.V., Melamed R., Trejo A., Ornatsky O.I., et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 2011, 332:687-696.
81. Amir el A.D., Davis K.L., Tadmor M.D., Simonds E.F., Levine J.H., Bendall S.C., Shenfeld D.K., Krishnaswamy S., Nolan G.P., Pe'er D. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat Biotechnol 2013, 31:545-552.
82. Wolchinsky R., Hod-Marco M., Oved K., Shen-Orr S.S., Bendall S.C., Nolan G.P., Reiter Y. Antigen-dependent integration of opposing proximal TCR-signaling cascades determines the functional fate of T lymphocytes. J Immunol 2014, 192:2109-2119.